No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 727,475 | 782,723 | 898,022 | 941,790 | 988,981 | 945,268 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 52,343 | 72,745 | 67,608 | 86,053 | 81,841 | 65,213 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Unicharm Corporation engages in the manufacturing and sale of pet care and related products in Japan and internationally. The company operates through Personal Care, Pet Care, and Others segments. It offers wellness care, feminine care, baby and child care products, as well as food-packaging materials, etc. The company also provides napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree brand name; specialized liners for incontinence care under the Charm Nap brand name; fabric and facial masks under the Chorittai and Chokaiteki Mask brand name; Home care products under Wave brand; and kitchen paper towel under the Cook Up brand name. In addition, it offers pet food under the Pet Dog Genki, Pet Cat Genki, Grand Deli, Best Balance, Silver Spoon, Silver Plate, AllWell, and Physicalife brand names, as well as excrement cleanup sheets, disposable diapers, apparel-like absorption wear for excretion-care for dogs, and Deo-Sand series and Deo-Toilet system products for cats. Further, the company provides feminine care products including feminine napkins, tampons, sanitary shorts, and panty liners under the Sofy and Silcot names; and disposable baby diaper under the Moony, Mamy Poko, Trepanman, and Oyasuminman brands. Additionally, it is involved in recycling of disposable diapers, as well as offering products under RefF brand. Unicharm Corporation was incorporated in 1941 and is headquartered in Minato, Japan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Unicharm Corporation (8113.T)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Unicharm Corporation engages in the manufacturing and sale of pet care and related products in Japan and internationally. The company operates through Personal Care, Pet Care, and Others segments. It offers wellness care, feminine care, baby and child care products, as well as food-packaging materials, etc. The company also provides napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree brand name; specialized liners for incontinence care under the Charm Nap brand name; fabric and facial masks under the Chorittai and Chokaiteki Mask brand name; Home care products under Wave brand; and kitchen paper towel under the Cook Up brand name. In addition, it offers pet food under the Pet Dog Genki, Pet Cat Genki, Grand Deli, Best Balance, Silver Spoon, Silver Plate, AllWell, and Physicalife brand names, as well as excrement cleanup sheets, disposable diapers, apparel-like absorption wear for excretion-care for dogs, and Deo-Sand series and Deo-Toilet system products for cats. Further, the company provides feminine care products including feminine napkins, tampons, sanitary shorts, and panty liners under the Sofy and Silcot names; and disposable baby diaper under the Moony, Mamy Poko, Trepanman, and Oyasuminman brands. Additionally, it is involved in recycling of disposable diapers, as well as offering products under RefF brand. Unicharm Corporation was incorporated in 1941 and is headquartered in Minato, Japan.
